SCHEMBL618853

SCHEMBL618853

[c]1ccc(-c2ccccc2)c(-c2ccccc2)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BACE1 P56817 1/20 0.39
▸ ALDH1A1 P00352 5/20 0.38
▸ HSD17B10 Q99714 2/20 0.37
▸ CYP2A6 P11509 2/20 0.37
▸ MAPK1 P28482 2/20 0.37
▸ HPGD P15428 1/20 0.37
▸ BCL2L1 Q07817 1/20 0.37
▸ PTGS2 P35354 1/20 0.34
▸ ALOX5 P09917 1/20 0.33
▸ DPP4 P27487 1/20 0.33
▸ GPR55 Q9Y2T6 1/20 0.32
▸ HDAC4 P56524 1/20 0.32
▸ HDAC2 Q92769 1/20 0.32
▸ HDAC8 Q9BY41 1/20 0.32
▸ HDAC6 Q9UBN7 1/20 0.32
▸ CYP2B6 P20813 1/20 0.32
▸ ALOX15 P16050 1/20 0.32
▸ NISCH Q9Y2I1 1/20 0.31
▸ DCUN1D1 Q96GG9 1/20 0.31
▸ TDP1 Q9NUW8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6474583 0.95 BACE1 (0.36) BACE1ALDH1A1HSD17B10CYP2A6MAPK1
SCHEMBL445102 0.95 ALDH1A1 (0.41) BACE1ALDH1A1HSD17B10CYP2A6MAPK1
SCHEMBL27629739 0.95 ALDH1A1 (0.41) BACE1ALDH1A1HSD17B10CYP2A6MAPK1
SCHEMBL6880077 0.95 ALDH1A1 (0.41) BACE1ALDH1A1HSD17B10CYP2A6MAPK1
SCHEMBL3870533 0.95 BACE1 (0.36) BACE1ALDH1A1HSD17B10CYP2A6MAPK1
SCHEMBL18832483 0.91 ALDH1A1 (0.39) BACE1ALDH1A1HSD17B10CYP2A6MAPK1
SCHEMBL9958265 0.88 NOTUM (0.52) ALDH1A1HSD17B10MAPK1NPC1RAB9A
SCHEMBL9957984 0.88 NOTUM (0.52) ALDH1A1HSD17B10MAPK1NPC1RAB9A
SCHEMBL9770283 0.88 PTGS2 (0.41) HPGDPTGS2
SCHEMBL6966765 0.88 MAOA (0.38) BACE1ALDH1A1ALOX5HDAC4HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 301 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113150007-A Photochromic indeno-fused ring pyran compounds 光学转变公司 2021-07-23 — — CN claimed
CN-110730778-A Photochromic indeno-fused phenanthropyran compounds 光学转变有限公司 2020-01-24 — — CN claimed
EP-2655374-A1 N-(1-(SUBSTITUTED-PHENYL)ETHYL)-9H-PURIN-6-AMINES AS PI3K INHIBITORS Incyte Corporation (US) 2013-10-30 — — EP claimed
WO-2012087881-A1 N-(1-(SUBSTITUTED-PHENYL)ETHYL)-9H-PURIN-6-AMINES AS PI3K INHIBITORS INCYTE CORPORATION (US) 2012-06-28 — — WO claimed
US-7482490-B2 Amine compound having fluorene group as framework, process for producing the amine compound, and use of the amine compound TOSOH CORPORATION (JP) 2009-01-27 — — US claimed
CN-100430052-C Cathepsin cysteine protease inhibitors MERCK FROSST CANADA INC (CA) 2008-11-05 — — CN claimed
US-20080194878-A1 Amine Compound Having Fluorene Group as Framework, Process for Producing the Amine Compound, and Use of the Amine Compound TOSOH CORPORATION (JP) 2008-08-14 — — US claimed
EP-1752440-A1 AMINE COMPOUND HAVING FLUORENE GROUP AS FRAMEWORK, PROCESS FOR PRODUCING THE AMINE COMPOUND, AND USE OF THE AMINE COMPOUND Tosoh Corporation (JP) 2007-02-14 — — EP claimed
CN-1638757-A Cathepsin cysteine protease inhibitors MERCK FROSST CANADA INC (CA) 2005-07-13 — — CN claimed
CN-118251380-A Spiro- (indan-fluorene) compounds and their use in organic electronic devices 多蒂肯独家合成控股公司 2024-06-25 — — CN disclosed
WO-2024128314-A1 POLYCYCLIC AROMATIC COMPOUND 国立大学法人京都大学 2024-06-20 — — WO disclosed
US-20240162466-A1 CARBON DIOXIDE ADSORPTION BATTERY AND CHARGE/DISCHARGE DEVICE KURARAY CO., LTD. (JP) 2024-05-16 — — US disclosed
US-20240122065-A1 METAL PATTERNING MATERIAL, AMINE COMPOUND, ELECTRONIC DEVICE, AND METHOD FOR FORMING METAL PATTERN TOSOH CORPORATION (JP) 2024-04-11 — — US disclosed
US-11877506-B2 Polycyclic aromatic compound KWANSEI GAKUIN EDUCATIONAL FOUNDATION (JP) 2024-01-16 — — US disclosed
US-5266171-A Electrochemical oxidation in and etherification BASF AKTIENGESELLSCHAFT (DE) 1993-11-30 — — US disclosed
US-5159117-A Reacting ketone or aldehyde with nitrites in presence of acid catalyst BASF AKTIENGESELLSCHAFT (DE) 1992-10-27 — — US disclosed
EP-0485783-A2 Process for producing epoxy compounds BASF Aktiengesellschaft (DE) 1992-05-20 — — EP disclosed
EP-0472118-A1 Process for production of alpha,alpha-dialkoxycetones BASF Aktiengesellschaft (DE) 1992-02-26 — — EP disclosed
EP-0460451-A1 Process for the preparation of alpha-hydroxymethyl-ketals BASF Aktiengesellschaft (DE) 1991-12-11 — — EP disclosed
US-4361707-A COBALT, IODINE AND A PHOSPHINE LIGAND GULF RESEARCH & DEVELOPMENT COMPANY (US) 1982-11-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11877506-B2 Polycyclic aromatic compound F11, C1R, RNF31 BACE1 1165/4885ALDH1A1 2814/4885HSD17B10 2668/4885
US-20080194878-A1 Amine Compound Having Fluorene Group as Framework, Process for Producing the Amine Compound, and Use of the Amine Compound TAAR1, SLC18A1, ADRB2 BACE1 3921/4885ALDH1A1 1351/4885HSD17B10 1406/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback